BackGW Pharmaceuticals Overview

GW Pharmaceuticals Other Assets

Track GW Pharmaceuticals's other assets ($33M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$33.01M
19.12% YoYΔ $5.30M vs prior year quarter

Peer trimmed avg / median

Loading

GW Pharmaceuticals Other Assets History

Loading

GW Pharmaceuticals vs. peers: Other Assets Comparison

Loading

GW Pharmaceuticals Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

GW Pharmaceuticals (GWPH) FAQ

As of the most recent data (March 2021), GWPH shows a other assets of $33M. That compares with $28M in the prior-year period — up 19.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GWPH's other assets is now $33M (was $28M) — a 19.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether GW Pharmaceuticals is outperforming or lagging.

Tracking GWPH's other assets over time shows whether GW Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $33M That compares with $28M in the prior-year period — up 19.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other assets page, Stockcircle has GW Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other assets (currently $33M) with ownership activity and broader fundamentals.

GW Pharmaceuticals's other assets is $33M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.